Benazepril Hydrochloride | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Benazepril Hydrochloride
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Benazepril Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 18 USDMF, 8 CEP/COS, 2 JDMF, 7 EU WC, 14 NDC API, 9 Listed Suppliers, $ API Reference Price

26 API Suppliers
18 USDMF
8 CEP/COS
2 JDMF
7 EU WC
14 NDC API
9 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

159 FDF Dossiers, 150 FDA Orange Book, 8 Canada, 1 Listed Dossiers

159 FDF Dossiers
150 FDA Orange Book
8 Canada
1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 20MG, TABLET;ORAL - 40MG, TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 10MG BASE;20MG, CAPSULE;ORAL - EQ 10MG BASE;40MG, CAPSULE;ORAL - EQ 2.5MG BASE;10MG, CAPSULE;ORAL - EQ 5MG BASE;10MG, CAPSULE;ORAL - EQ 5MG BASE;20MG, CAPSULE;ORAL - EQ 5MG BASE;40MG

TABLET;ORAL - 10MG
TABLET;ORAL - 20MG
TABLET;ORAL - 40MG
TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - EQ 10MG BASE;20MG
CAPSULE;ORAL - EQ 10MG BASE;40MG
CAPSULE;ORAL - EQ 2.5MG BASE;10MG
CAPSULE;ORAL - EQ 5MG BASE;10MG
CAPSULE;ORAL - EQ 5MG BASE;20MG
CAPSULE;ORAL - EQ 5MG BASE;40MG

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 12 DKSH, 8 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 9 Nanjing Well Pharmaceutical, 4 Kirsch Pharma, 4 ACG Worldwide, 6 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 1 Avesta Pharma, 36 BASF, 2 Clariant, 11 Corel Pharma Chem, 6 DFE Pharma, 1 Esteem Industries, 2 Finar, 13 Gangwal Chemicals, 5 Ideal Cures, 3 Ingredion Pharma Solutions, 26 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 20 Roquette, 16 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

65 Fillers, Diluents & Binders, 51 Coating Systems & Additives, 38 Direct Compression, 35 Thickeners and Stabilizers, 34 Granulation, 34 Solubilizers, 32 Disintegrants & Superdisintegrants, 27 Controlled & Modified Release, 25 Lubricants & Glidants, 24 Topical, 19 Parenteral, 19 Film Formers & Plasticizers, 14 Emulsifying Agents, 13 Co-Processed Excipients, 11 Chewable & Orodispersible Aids, 10 Surfactant & Foaming Agents, 9 Empty Capsules, 9 Taste Masking, 7 API Stability Enhancers, 7 Rheology Modifiers, 5 Coloring Agents, 4 Vegetarian Capsules

65 Fillers, Diluents & Binders
51 Coating Systems & Additives
38 Direct Compression
35 Thickeners and Stabilizers
34 Granulation
34 Solubilizers
32 Disintegrants & Superdisintegrants
27 Controlled & Modified Release
25 Lubricants & Glidants
24 Topical
19 Parenteral
19 Film Formers & Plasticizers
14 Emulsifying Agents
13 Co-Processed Excipients
11 Chewable & Orodispersible Aids
10 Surfactant & Foaming Agents
9 Empty Capsules
9 Taste Masking
7 API Stability Enhancers
7 Rheology Modifiers
5 Coloring Agents
4 Vegetarian Capsules

DIGITAL CONTENT

4 News #PharmaBuzz

4 News #PharmaBuzz

GLOBAL SALES INFORMATION

6 US Medicaid Prescriptions, 20 Regulatory FDF Prices

6 US Medicaid Prescriptions
20 Regulatory FDF Prices

MARKET PLACE

2 APIs

2 APIs

PATENTS & EXCLUSIVITIES

5 Health Canada Patents

5 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 1 Others

3 EDQM
1 USP
1 Others

$ API Ref.Price (USD/KG) : 997 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

5 All

01 5Ceva Animal Health Inc.

filter Patent Reset all filters

5 All

01 22696961

02 32875229

filter Product Reset all filters

5 All

01 5SPIRONOLACTONE | BENAZEPRIL HYDROCHLORIDE

filter Dosage Reset all filters

5 All

01 5TABLET (CHEWABLE)

filter Exp Date Reset all filters

5 All

01 22028-06-25

02 32033-06-01

Nuray Benazepril HCl

Product Main Page

01

Ceva Animal Health Inc.

Spironolactone, Benazepril Hydrochloride

CPhI Korea

Not Confirmed

Ceva Animal Health Inc.

Country

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-06-01

Date Granted : 2020-10-13

Spironolactone, Benazepril Hydrochloride

Brand Name : CARDALIS

Patent Number : 2875229

Filing Date : 2013-06-01

Strength per Unit : 20mg / 2.5mg

Dosage Form : TABLET (CHEWABLE)

Human Or VET : Veterinary

Route of Administration : ORAL

Patent Expiration Date : 2033-06-01

Date Granted : 2020-10-13

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Ceva Animal Health Inc.

Spironolactone, Benazepril Hydrochloride

CPhI Korea

Not Confirmed

Ceva Animal Health Inc.

Country

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-06-01

Date Granted : 2020-10-13

Spironolactone, Benazepril Hydrochloride

Brand Name : CARDALIS

Patent Number : 2875229

Filing Date : 2013-06-01

Strength per Unit : 40mg / 5mg

Dosage Form : TABLET (CHEWABLE)

Human Or VET : Veterinary

Route of Administration : ORAL

Patent Expiration Date : 2033-06-01

Date Granted : 2020-10-13

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Ceva Animal Health Inc.

Spironolactone, Benazepril Hydrochloride

CPhI Korea

Not Confirmed

Ceva Animal Health Inc.

Country

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-06-25

Date Granted : 2018-07-31

Spironolactone, Benazepril Hydrochloride

Brand Name : CARDALIS

Patent Number : 2696961

Filing Date : 2008-06-25

Strength per Unit : 40mg / 5mg

Dosage Form : TABLET (CHEWABLE)

Human Or VET : Veterinary

Route of Administration : ORAL

Patent Expiration Date : 2028-06-25

Date Granted : 2018-07-31

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Ceva Animal Health Inc.

Spironolactone, Benazepril Hydrochloride

CPhI Korea

Not Confirmed

Ceva Animal Health Inc.

Country

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-06-01

Date Granted : 2020-10-13

Spironolactone, Benazepril Hydrochloride

Brand Name : CARDALIS

Patent Number : 2875229

Filing Date : 2013-06-01

Strength per Unit : 80mg / 10mg

Dosage Form : TABLET (CHEWABLE)

Human Or VET : Veterinary

Route of Administration : ORAL

Patent Expiration Date : 2033-06-01

Date Granted : 2020-10-13

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

Ceva Animal Health Inc.

Spironolactone, Benazepril Hydrochloride

CPhI Korea

Not Confirmed

Ceva Animal Health Inc.

Country

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-06-25

Date Granted : 2018-07-31

Spironolactone, Benazepril Hydrochloride

Brand Name : CARDALIS

Patent Number : 2696961

Filing Date : 2008-06-25

Strength per Unit : 80mg / 10mg

Dosage Form : TABLET (CHEWABLE)

Human Or VET : Veterinary

Route of Administration : ORAL

Patent Expiration Date : 2028-06-25

Date Granted : 2018-07-31

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!